[3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate

C28H26FN3O4 — CID 130274338

IUPAC[3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate
SMILESCc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4c(F)cccc34)c(OC(=O)O)[nH]c12
InChIInChI=1S/C28H26FN3O4/c1-16-25(17(2)32(3)31-16)22-11-4-10-20-21(27(30-26(20)22)36-28(33)34)12-7-15-35-24-14-6-8-18-19(24)9-5-13-23(18)29/h4-6,8-11,13-14,30H,7,12,15H2,1-3H3,(H,33,34)
InChIKeyODKKZNYKXINHIT-UHFFFAOYSA-N
MW487.53 g/mol
LogP6.55
Rot. Bonds7

About [3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate

[3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate (PubChem CID 130274338) has the molecular formula C28H26FN3O4 and a molecular weight of 487.53 g/mol. Its IUPAC name is [3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate.

Molecular Properties

Compound Name[3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate
PubChem CID130274338
Molecular FormulaC28H26FN3O4
Molecular Weight487.53 g/mol
Exact Mass487.19
IUPAC Name[3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate
SMILESCc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4c(F)cccc34)c(OC(=O)O)[nH]c12
InChIInChI=1S/C28H26FN3O4/c1-16-25(17(2)32(3)31-16)22-11-4-10-20-21(27(30-26(20)22)36-28(33)34)12-7-15-35-24-14-6-8-18-19(24)9-5-13-23(18)29/h4-6,8-11,13-14,30H,7,12,15H2,1-3H3,(H,33,34)
InChIKeyODKKZNYKXINHIT-UHFFFAOYSA-N
XLogP6.55
TPSA89.37 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500487.53
LogP ≤ 56.55
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze [3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate?
The IUPAC name of [3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate (CID 130274338) is [3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate.
What is the SMILES notation for [3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate?
The canonical SMILES for [3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate is Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4c(F)cccc34)c(OC(=O)O)[nH]c12.
What is the InChIKey of [3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate?
The InChIKey is ODKKZNYKXINHIT-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H26FN3O4/c1-16-25(17(2)32(3)31-16)22-11-4-10-20-21(27(30-26(20)22)36-28(33)34)12-7-15-35-24-14-6-8-18-19(24)9-5-13-23(18)29/h4-6,8-11,13-14,30H,7,12,15H2,1-3H3,(H,33,34).
What are the key properties of [3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate?
[3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate has a molecular weight of 487.53 g/mol, XLogP of 6.55, 7 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [3-[3-(5-fluoronaphthalen-1-yl)oxypropyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1H-indol-2-yl] hydrogen carbonate is sourced from PubChem (CID 130274338), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).